Navigation Links
Cellectis Sues Precision BioSciences for Infringement of its Patents Concerning Meganuclease Technology
Date:3/13/2008

BIOCITECH PARK, ROMAINVILLE, France, March 13 /PRNewswire-FirstCall/ -- Cellectis SA (NYSE: ALCLS), a world leader in rational genome engineering, has announced today that it filed a patent infringement lawsuit against Precision BioSciences, Inc. in the United States District Court for the Eastern District of North Carolina. The lawsuit seeks a declaration that, by making and selling certain meganucleases, Precision BioSciences infringes two Cellectis patents relating to its proprietary meganuclease recombination systems. The Precision Biosciences' meganucleases at issue are intended to target site-specific DNA breaks and effect a desired genome modification in a given transgenic organism, such as a plant. The lawsuit seeks both monetary damages for infringement, as well as a permanent injunction preventing Precision BioSciences from any further making, using or selling of such meganucleases. "We take our intellectual property rights very seriously and intend to vigorously pursue this patent infringement case," said Dr. Andre Choulika, CEO and co-founder of Cellectis SA., and the man who participated in coining the term "meganuclease."

Since its creation in January 2000 and throughout its development, Cellectis has made special efforts to protect new discoveries made by its research team as well as those of its partner, the world-renowned Institut Pasteur. Cellectis currently owns the exclusive rights to over 35 issued patents and 113 pending patent applications. Most of these patents are based on Cellectis' fully integrated genome engineering system referred to as its Meganuclease Recombination Systems (MRSs). These systems offer natural, efficient, precise and flexible genome surgery with several applications, among others, in t
'/>"/>

SOURCE Cellectis SA
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related biology technology :

1. Varian Medical Systems Exhibits Latest Technologies and Products Designed to Improve Speed and Precision of Radiotherapy at ESTRO 2007
2. DuPont and Precision BioSciences Collaborate to Accelerate Crop Product Development
3. Time Domain Showcases Precision Location Capability of Ultra Wideband PLUS Product Line at HIMSS 2008
4. YM BIOSCIENCES ANNOUNCES COMPLIANCE WITH AIM RULE 26
5. Selection of Development Candidate Triggers $0.5 Million Milestone Payment to Ardea Biosciences, Inc.
6. ImmuneRegen BioSciences Files 8-K that Highlights Enclosed Shareholder Letter Discussing Recent Achievements and Outlook
7. ONCOSCIENCE AG, THE EUROPEAN PARTNER OF YM BIOSCIENCES, ANNOUNCES COMPLETION OF PATIENT ENROLLMENT IN PHASE III BRAIN CANCER TRIAL OF NIMOTUZUMAB
8. Pressure BioSciences, Inc. Reports Second Quarter 2007 Financial Results and Provides Business Update
9. YM BIOSCIENCES, EUROPEAN PARTNER, ONCOSCIENCE AG, ANNOUNCES INITIATION OF ADVANCED NIMOTUZUMAB TRIALS IN ADULT GLIOMA AND PANCREATIC CANCER
10. Monogram Biosciences to Present at the Thomas Weisel Partners Healthcare Conference 2007
11. Magellan Biosciences Names Steven E. Diamond, PhD, Chief Scientific Officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/5/2008).../ - YM BioSciences Inc. (NYSE Alternext US:YMI, TS...es, develops and commercializes differentiated pro...Oncoscience AG, the European licensee of nimotuzum...as withdrawn its application to the European Medic...nimotuzumab. Withdrawal of an application does not...
(Date:12/4/2008)...avrille, Inc.,(OTC Bulletin Board: FVRL) and MyMe...ion company focused on secure Web-based storage of...nced today that two significant conditions,requir...ement have been met. , (Logo: http://www.... "We are pleased to announce that Favrille cr...
(Date:12/4/2008)...tial vaccine for low-resource countries , , ...e/ -- The biotech company Lentigen Corporation and...ounced today a partnership to accelerate research ...ly invest $3 million over 27 months and work with ...s-like particle (VLP) prototype pandemic influenza...
(Date:12/4/2008)...ll/ -- Raymond J. De Hont, Chairman and Chief Exec..., announced today that the Company,s Board of Dire...red a quarterly dividend of $0.06 per share payabl...he close of business on February 26, 2009. This d...eriod last year. , , This is the thirty-fou...
Breaking Biology Technology:YM BIOSCIENCES PROVIDES EU REGULATORY UPDATE 2YM BIOSCIENCES PROVIDES EU REGULATORY UPDATE 3Favrille and MyMedicalRecords.com, Inc. Obtain Shareholder Approval to Move Forward With Merger 2Favrille and MyMedicalRecords.com, Inc. Obtain Shareholder Approval to Move Forward With Merger 3Favrille and MyMedicalRecords.com, Inc. Obtain Shareholder Approval to Move Forward With Merger 4Favrille and MyMedicalRecords.com, Inc. Obtain Shareholder Approval to Move Forward With Merger 5Lentigen Corporation and PATH Announce Partnership on Innovative Vaccine for Pandemic Influenza 2Lentigen Corporation and PATH Announce Partnership on Innovative Vaccine for Pandemic Influenza 3Met-Pro Corporation Declares Quarterly Dividend 2
...be impressive enough if the robotics engineering t... Louis Park, Minn., had won a national championshi...re impressive that their competitors were seasoned...mp, students from the Minneapolis-area school comp...e 2005 U.S. Open RoboCup. Using robots to navigate...
...ays, Promega Corp . has given Northwestern Mutua...Quiet to those outside the life-science realm, tha... Madison walls, it,s anything but silent, as a con...hat innovation has produced about 200 patents and ...ew product innovations since 2002. , ,That pace ha...
... , a Madison-based stock image distributor, has be...g to a report in pdn online . , ,Terms of the d...dly is part of a business strategy for Getty Image... of customers. , ,PunchStock employs 60 people an... Kingdom. It offers royalty-free images and distri...
...0th in a series of articles on developing start-up...ors. , , Madison, Wis. - In Step 9 we discusse...me we focus specifically on the federal laws. , ,...bject to both state and federal securities laws an...ies laws of those states from and into which a bus...
Other Biology Technology:Silver linings in the cloud: America's dearth of STEM students 2Silver linings in the cloud: America's dearth of STEM students 3Silver linings in the cloud: America's dearth of STEM students 4Promega Corporation: Wisconsin's quiet innovator 2Promega Corporation: Wisconsin's quiet innovator 3Promega Corporation: Wisconsin's quiet innovator 4Promega Corporation: Wisconsin's quiet innovator 5Early Stage 10: The nuances of federal laws 2Early Stage 10: The nuances of federal laws 3Early Stage 10: The nuances of federal laws 4Early Stage 10: The nuances of federal laws 5
(Date:12/3/2008)...Richard H. Jones, deputy executive director of the...rld Energy Outlook 2008" Dec. 9 at Rice University...ll address such questions as: Is the world facing ...nvestment? What type of post-Kyoto policy framewor...ation levels, and what impact might such a policy ...
(Date:12/3/2008)...GAINESVILLE, Fla. The wild pea pod is big and hea...hade of its parent plant. , And yet, like a grou...den, it manages if it has a reasonable chance of ...ing at the world,s largest experimental landscape ... woods or other natural areas have discovered the...
(Date:12/3/2008)...Using a harmless virus to insert a corrective gene...ildren,s Research Hospital have alleviated sickle ...archers found that the treated mice showed essenti...scientists caution that applying the gene therapy ..., they believe that the new therapy will become an...
(Date:12/3/2008)...A multi-institution team of investigators led by r...niversity of Southern California (USC) has receive...tes of Mental Health (NIMH) for a groundbreaking e...ousands of patients in order to study the genetic ... The USC Center for Genomic Psychiatry and Massach...
Breaking Biology News(10 mins):'World Energy Outlook' to be presented at Rice University Dec. 9 2Rooted plants move mysteriously down greenways, scientists say 2Rooted plants move mysteriously down greenways, scientists say 3Gene therapy corrects sickle cell disease in laboratory study 2Gene therapy corrects sickle cell disease in laboratory study 3USC researchers head global effort to study genetic risks that contribute to psychiatric diseases 2USC researchers head global effort to study genetic risks that contribute to psychiatric diseases 3Dr Dan L Fortenbacher O D FCOVD Becomes 29th President of College of Optometrists in Vision Development 28COVD 29 3B Unveils 7 Part Development 5415 1Dr Dan L Fortenbacher O D FCOVD Becomes 29th President of College of Optometrists in Vision Development 28COVD 29 3B Unveils 7 Part Development 5415 2Dr Dan L Fortenbacher O D FCOVD Becomes 29th President of College of Optometrists in Vision Development 28COVD 29 3B Unveils 7 Part Development 5415 3AUDIO from Medialink and P 26G 3A New Tools for Promoting Good Mouth Health 5413 1Lung Cancer Alliance Launches Lung Cancer Awareness Month With Third Annual Report Card on Lung Cancer 5411 1Lung Cancer Alliance Launches Lung Cancer Awareness Month With Third Annual Report Card on Lung Cancer 5411 2XTENT Announces Third Quarter 2007 Financial Results 5409 1XTENT Announces Third Quarter 2007 Financial Results 5409 2XTENT Announces Third Quarter 2007 Financial Results 5409 3XTENT Announces Third Quarter 2007 Financial Results 5409 4
...breathing a sigh of relief, as they no longer run ...ase-fighting substances. Scientists recently disco...h lives symbiotically inside the sea squirt, actua...hat may one day be used in cancer treatment. , Des...cessfully cultivate Prochloron in the laboratory o...
...ences Professor Daniel F. Eberl and his colleagues... leading to deafness in fruit flies that may shed ... "Myosin VIIA Defects, which Underlie the Usher 1B...a," is scheduled for publication in the May 10 iss...eir recent work -- showing that loss of function i...
...nd in blood, can be fused with large, protein-base...tor (G-CSF) to create a new oral compound that is ...ointestinal (GI) tract and then able to cross over...rding to research from the University of Southern ...ay allow for oral administration of drugs that pre...
...bugs. The rates of drug-resistant bacteria infecti...ave been increasing steadily in recent years, acco...linical Infectious Diseases, now available online....problem due in part to inappropriate prescribing a...uperbugs" can infect people and cause health probl...
Other Biology News:UI researcher studies deafness in fruit flies, humans 2Recombinant DNA technology may enable oral, rather than injectable, delivery of protein drugs 2Recombinant DNA technology may enable oral, rather than injectable, delivery of protein drugs 3Two studies document rise of superbugs in the environment 2Two studies document rise of superbugs in the environment 3
...ne TC-512 is the only Gradient thermal cycler whic...touch of a screen. ,Wide linear gradient - The m...amazing range of,30C. Protocols can be optimised i...ene Gradient incorporates a large, 115 x 90mm, tou...
...dom EVO Clinical is Tecans open platform for clini... to enhance quality, safety and performance in the...afety is provided by flexible barcode reading and ...ention that the system complies with the IVD-Direc...
Request Info
Features Provides a buffered anti-freeze environment for enzyme conjugated antibodies and proteins , Maintains a liquid, low viscosity solution at -20C , No aliquoting of conjugate is necessary an
Biology Products: